These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26107473)

  • 41. Short-Term Outcomes of Pediatric Keratoprosthesis With the Near-Complete Conjunctival Flap.
    Bawany MH; Kudla C; Khan FA; Chung MM; Aquavella JV
    Cornea; 2021 Jun; 40(6):679-684. PubMed ID: 33941714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Visual rehabilitation with keratoprosthesis after tenonplasty as the primary globe-saving procedure for severe ocular chemical injuries.
    Iyer G; Srinivasan B; Agarwal S; Barbhaya R
    Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1787-93. PubMed ID: 22546999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Boston type 1 keratoprosthesis for chemical and thermal injury.
    Phillips DL; Hager JL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Cornea; 2014 Sep; 33(9):905-9. PubMed ID: 25055151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
    Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
    Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
    Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
    J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and vitreoretinal management of retinal detachment in eyes with Boston keratoprosthesis.
    Petrou P; Banerjee PJ; Wilkins MR; Singh M; Eastlake K; Limb GA; Charteris DG
    Br J Ophthalmol; 2017 May; 101(5):629-633. PubMed ID: 27565989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.
    Shanbhag SS; Saeed HN; Colby KA; Chodosh J
    Cornea; 2018 Nov; 37(11):1408-1413. PubMed ID: 30179893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.
    Phillips DL; Goins KM; Greiner MA; Alward WL; Kwon YH; Wagoner MD
    Cornea; 2015 Nov; 34(11):1383-6. PubMed ID: 26398156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.
    Lim JI; Machen L; Arteaga A; Karas FI; Hyde R; Cao D; Niec M; Vajaranant TS; Cortina MS
    Retina; 2018 Sep; 38 Suppl 1(Suppl 1):S125-S133. PubMed ID: 29370031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of aniridia with Boston type I keratoprosthesis.
    Rixen JJ; Cohen AW; Kitzmann AS; Wagoner MD; Goins KM
    Cornea; 2013 Jul; 32(7):947-50. PubMed ID: 23449480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of glaucoma with Boston type 1 keratoprosthesis.
    Utine CA; Arıkan G; Yardım E; Günenç Ü
    Arq Bras Oftalmol; 2023; 86(2):137-144. PubMed ID: 35417518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomical and functional outcomes of Boston type I keratoprosthesis as primary penetrating corneal procedure in high-risk and non-high-risk cases.
    Lázaro-Rodríguez V; Barraquer RI; Julio G; Bolaños J; Álvarez de Toledo J; de la Paz MF
    Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):161-170. PubMed ID: 35857089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.